Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Rapid Dose Therapeutics Corp (RDTCF) Stock Price & Analysis

0 Followers

RDTCF Stock Chart & Stats

$0.07$0.00(0.00%)
At close: 4:00 PM EST
$0.06$0.07$0.08$0.09Aug 4Aug 28Sep 3Sep 30Oct 20Nov 2
Day’s Range
$0.07 - $0.07
52-Week Range
$0.01 - $0.15
Previous Close
$0.07
Volume
N/A
Average Volume (3M)
8,975
Market Cap
$10.24M
Enterprise Value
$21.70M
Total Cash (Recent Filing)
$8,625
Total Debt (Recent Filing)
$5.38M
Price to Earnings (P/E)
―
Beta
0.20
Next Earnings
Feb 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Improved Cash Generation

TTM operating and free cash flow of about $0.42M indicates a recent improvement in cash conversion and financial discipline. If maintained, this could help fund operations without immediate external capital, although durability depends on working-capital and spending patterns.

Proprietary Delivery Platform

QuickStrip gives Rapid Dose a defined technology platform that can be applied across pharmaceuticals, nutraceuticals, and other active compounds. Its focus on formulation, intellectual property, and licensing creates potential for scalable partner-led commercialization beyond direct product sales.

Modestly Narrower Losses

The modest reduction in losses suggests some improvement in operating performance relative to earlier periods, even though profitability remains weak. Continued progress could reduce cash requirements and support eventual breakeven, provided revenue stabilizes and costs do not rise faster.

Bears Say

Declining Revenue

Revenue contraction indicates that recent commercial momentum has weakened after several years of growth from a small base. A smaller revenue platform makes it harder to absorb fixed costs, fund development, and demonstrate that the QuickStrip model can scale sustainably.

Severe Unprofitability

Negative gross profit and a deeply negative net margin show that the current revenue base does not cover the underlying cost structure. This limits internal funding capacity and means the company remains dependent on a substantial improvement in monetization or operating efficiency.

Strained Balance Sheet

The sustained equity deficit and debt exceeding the asset base leave the company with little balance-sheet cushion. This weakens financial flexibility, increases refinancing and dilution risk, and can constrain investment in platform development while losses remain significant.

Rapid Dose Therapeutics Corp News

RDTCF FAQ

What was Rapid Dose Therapeutics Corp’s price range in the past 12 months?
Rapid Dose Therapeutics Corp lowest stock price was $0.01 and its highest was $0.15 in the past 12 months.
What is Rapid Dose Therapeutics Corp’s market cap?
Rapid Dose Therapeutics Corp’s market cap is $10.24M.
When is Rapid Dose Therapeutics Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rapid Dose Therapeutics Corp’s earnings last quarter?
Rapid Dose Therapeutics Corp released its earnings results on Oct 30, 2026. The company reported -$0.004 earnings per share for the quarter.
Is Rapid Dose Therapeutics Corp overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Rapid Dose Therapeutics Corp pay dividends?
Rapid Dose Therapeutics Corp does not currently pay dividends.
What is Rapid Dose Therapeutics Corp’s EPS estimate?
Rapid Dose Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rapid Dose Therapeutics Corp have?
Rapid Dose Therapeutics Corp has 137,782,930 shares outstanding.
What happened to Rapid Dose Therapeutics Corp’s price movement after its last earnings report?
Rapid Dose Therapeutics Corp reported an EPS of -$0.004 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Rapid Dose Therapeutics Corp?
Currently, no hedge funds are holding shares in RDTCF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology